Search Results
FOCUS AREA
Public Health and Well-Being
Addressing health disparities through collaboration, innovation, and evaluation
SOLUTION
Medicinal Chemistry
Identifying ligands as tools to help clients search for new and better drugs and disease therapies
Showing results 1 to 20 of 22.
News Release
FDA Approves Breakthrough Drug to Treat Extensively Drug-Resistant Tuberculosis
August 14, 2019
RTI In The Media
Doris Rouse's Lifelong Journey to Save Those Suffering from Tuberculosis
November 08, 2019 - Triangle Business Journal
Focus Area
Preventing Substance Use
RTI In The Media
FDA OKs 'Game Changer' Pretomanid for Highly Resistant TB
August 15, 2019 - Medscape
News Release
RTI International Licenses Portfolio of Compounds to APIE Therapeutics
August 25, 2020
Impact
Novel Solutions: The Chemistry Center for Combating Antibiotic Resistant Bacteria (CC4CARB)
September 26, 2022
RTI In The Media
Drug Resistant TB: ‘Groundbreaking’ Drug Approved by U.S. Regulators
August 14, 2019 - The Telegraph
RTI In The Media
Triangle biotech startup aims to slow disease progression with RTI compounds
March 23, 2023 - WRAL TechWire
RTI In The Media
Breakthrough in Fight Against Multi-Resistant Tuberculosis
September 02, 2019 - Forbes
RTI In The Media
Drug Resistant TB: ‘Groundbreaking’ Drug Approved by U.S. Regulators
August 15, 2019 - Yahoo News UK
RTI In The Media
Cannabis’s Chemical Synergies
August 28, 2019 - Nature
RTI In The Media
Former Greensboro Girl Scout, Grimsley Grad Helps Find Cure for Deadly TB Strain
September 07, 2019 - Greensboro News & Record
RTI In The Media
Ep 41: Bruce Blough, Elliott Pauli & CC4CARB
September 05, 2022 - The AMR Studio Podcast
Focus Area
Substance Use Research
Announcement
RTI International researchers awarded grant funding to explore drugs for chronic pain, cancer
January 08, 2019
RTI In The Media
After 20 Years of Research, RTI Drug Approved for Drug-Resistant Tuberculosis
August 14, 2019 - Triangle Business Journal
RTI In The Media
Research Triangle Park Home to Breakthrough in Combating Drug-Resistant Tuberculosis
November 12, 2019 - CBS 17
Announcement
New Paper Describes Accurate, Scalable Method for Detecting Fragile X Syndrome in Newborns
March 05, 2020
RTI In The Media
How K2 and Other Synthetic Cannabinoids Got Their Start
November 28, 2018 - The Scientist
Announcement
RTI Secures Chemistry Center for Combating Antibiotic Resistance (CC4CARB) Contract from National Institute of Allergy and Infectious Diseases to Address Bottlenecks in Early Antibiotic Drug Discovery
April 16, 2021